LISOCABTAGENE MARALEUCEL for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where LISOCABTAGENE MARALEUCEL was used for Diffuse large b-cell lymphoma refractory.
Most Reported Side Effects for LISOCABTAGENE MARALEUCEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 315 | 42.7% | 48 | 189 |
| Immune effector cell-associated neurotoxicity syndrome | 129 | 17.5% | 22 | 74 |
| Neurotoxicity | 101 | 13.7% | 7 | 68 |
| Pyrexia | 47 | 6.4% | 3 | 37 |
| Fatigue | 38 | 5.2% | 2 | 9 |
| Hypotension | 38 | 5.2% | 8 | 26 |
| Febrile neutropenia | 28 | 3.8% | 2 | 26 |
| Confusional state | 27 | 3.7% | 1 | 22 |
| Death | 25 | 3.4% | 25 | 5 |
| Lymphocyte adoptive therapy | 25 | 3.4% | 4 | 19 |
| Malignant neoplasm progression | 23 | 3.1% | 13 | 10 |
| Platelet count decreased | 23 | 3.1% | 8 | 5 |
| Tremor | 22 | 3.0% | 1 | 13 |
| Aphasia | 21 | 2.9% | 1 | 16 |
| Neutropenia | 21 | 2.9% | 5 | 11 |
Other Indications for LISOCABTAGENE MARALEUCEL
Diffuse large b-cell lymphoma (347)
B-cell lymphoma (57)
Product used for unknown indication (56)
Chronic lymphocytic leukaemia (47)
Follicular lymphoma (38)
Mantle cell lymphoma (25)
Diffuse large b-cell lymphoma recurrent (16)
Non-hodgkin's lymphoma (15)
Marginal zone lymphoma (10)
B-cell lymphoma refractory (8)
Other Drugs Used for Diffuse large b-cell lymphoma refractory
RITUXIMAB (667)
EPCORITAMAB-BYSP (353)
AXICABTAGENE CILOLEUCEL (336)
BENDAMUSTINE (283)
CYCLOPHOSPHAMIDE (226)
POLATUZUMAB VEDOTIN (223)
ETOPOSIDE (165)
POLATUZUMAB VEDOTIN-PIIQ (158)
GEMCITABINE (147)
LENALIDOMIDE (143)